Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002408191 | SCV002722590 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-01-07 | criteria provided, single submitter | clinical testing | The c.1067delC variant, located in coding exon 1 of the MET gene, results from a deletion of one nucleotide at nucleotide position 1067, causing a translational frameshift with a predicted alternate stop codon (p.P356Qfs*28). This alteration is expected to result in premature protein truncation or nonsense-mediated mRNA decay. However, loss of function of MET has not been clearly established as a mechanism of disease. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005032265 | SCV005673756 | uncertain significance | Osteofibrous dysplasia; Papillary renal cell carcinoma type 1; Hepatocellular carcinoma; Autosomal recessive nonsyndromic hearing loss 97; Arthrogryposis, distal, IIa 11 | 2024-01-17 | criteria provided, single submitter | clinical testing |